HDAC9 and cancer: Despite evidence from the literature that HDAC inhibitors are promising therapy to block MDSCs function in several cancers, it remains unknown the key molecular mechanisms by which HDACs specifically regulate MDSCs function – a major drawback to current cancer immunotherapies.